Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q4 2023 Earnings

15MarConfirmed

Q4 2023

-0.59

-0.26

0.08

0.41

Details

Expected EPS

N/A

Actual EPS

-0.59

Surprise EPS

-0.59

Surprise Percent

+∞%

Description

Contineum Therapeutics (CTNM) has reported earnings of -0.59 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.